From WisPolitics.com/WisBusiness.com …
— SHINE Technologies has entered a distribution agreement with Taiwanese nuclear medicine company Primo Biotechnology.
The Janesville business recently announced the agreement, which grants Primo exclusive rights to distribute SHINE’s Illumira product in Taiwan as well as other sales rights in Japan, South Korea and Singapore.
Illumira, which contains the isotope lutetium-177, is used alongside a “cancer-seeking molecule” to target tumors and kill cancer cells with radiation while limiting damage to healthy cells. SHINE produces Lu-177 and other medical isotopes, and is developing fusion technology for various applications.
Primo will get “priority access” to the therapeutic isotopes, supplying nuclear medicine applications in these countries. Along with common and advanced radiopharmaceuticals, the business also provides pre-clinical research services, scientific consulting and more.
Dr. Ya-Yao Huang, CEO of Primo Biotechnology, says the agreement “marks a pivotal step in bringing precision and hope” to patients in the Pacific region.
“By partnering with SHINE, we ensure a stable supply of high-quality isotopes and advance cancer care in the region,” Huang said in a statement.
Meanwhile, SHINE is also expanding its Cassiopeia facility in Janesville to meet higher global demand for its radioisotopes.
Financial details of the agreement were not disclosed.
See the release below, and see more at Madison Startups.
— WisPolitics and WisBusiness.com are hosting a virtual luncheon tomorrow at noon to explore how policymakers and the health care community can improve youth mental health.
The one-hour event will feature four panelists:
- Maureen Busalacchi, director of the Division of Alcohol Policy Prevention and Research at the Medical College of Wisconsin and current president of the Wisconsin Public Health Association Inc.
- Dr. Mary Pfeiffer, retired (2024) Neenah Joint School District superintendent;
- Debbie Patz, vice president of Bellin Psychiatric Center, Emplify Health;
- And Erich Pfeifer, president and CEO of Marine Travelift.
Register for the free event here.
Top Stories
– Dementia cases expected to double by 2060: Study
– Drugmakers hiked prices for hundreds of drugs in early January
– US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
– Even Adults May Soon Be Vulnerable to ‘Childhood’ Diseases
– Biden Health Officials Say They Built up US Pandemic Defenses. Trump Promises Changes
– How Trump’s Greenland demands could impact Ozempic costs
– Voters Backed Abortion Rights But State Judges Have Final Say
Press Releases
– SHINE Technologies and Primo Biotech: Partner to advance precision cancer care in Asia-Pacific
